Drug profile · INN
homatropine methylbromide
HOMAPIN-10
homatropine methylbromide (HOMAPIN-10) is a unknown. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — homatropine methylbromide
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
homatropine methylbromide (HOMAPIN-10) is a unknown. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is homatropine methylbromide?
homatropine methylbromide (HOMAPIN-10) is a unknown. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for homatropine methylbromide?
HOMAPIN-10 is a marketed brand name for homatropine methylbromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of homatropine methylbromide?
homatropine methylbromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.